BioCapital
Filter News
Found 30,610 articles
-
It’s a busy week for the U.S. Food and Drug Administration (FDA) with quite a number of pending drug approvals, several of which were delayed for a variety of reasons. Here’s a look.
-
March is women’s History Month, with March 8 designated as International Women’s Day. Let’s take a look at 10 pioneers, some still alive, and some who are no longer with us, who are pioneers in the field of biotechnology.
-
Wounded Warrior Project Empowers Veterans Through The Honor Foundation
3/18/2019
Wounded Warrior Project® (WWP) announces a new partnership with The Honor Foundation (THF), a nonprofit that has developed a nationally recognized transition program for the military's special operations forces community.
-
Partnership for a Healthier America Announces 2019 Summit Sponsors
3/18/2019
Powerhouse Retail Consumer Brands, Childcare and Healthcare Leaders to Sponsor the Accelerating a Healthier Future Summit, April 1-2
-
Advancing Eyecare Announces Appointment of Brad Staley as Chief Executive Officer
3/18/2019
Experienced CEO with Global Operating Expertise to Oversee Lombart Instrument, Marco Ophthalmic, INNOVA Medical Ophthalmics, and Enhanced Medical Services
-
Tip That Launched College Bribery Scandal Case Came From Pharma Pump-and-Dump Investigation
3/15/2019
The scandal, dubbed Operation Varsity Blues, revolves around dozens of wealthy parents paying a college consultant to help cheat on entrance exams and falsify student athlete profiles, as well as bribing coaches at a number of prestigious universities. -
During his relatively brief tenure as Commissioner of the U.S. Food and Drug Administration (FDA), Scott Gottlieb has worked to streamline and advance guidelines for clinical trials. As something of a parting shot, Gottlieb made a statement criticizing the industry’s reluctance to take advantage ...
-
The White House budget proposal released earlier this week that slashed spending on the National Institutes of Health and Medicare programs has put members of the administration, including Health and Human Services Secretary Alex Azar on the defensive.
-
The research has broad potential for targeted treatments for neurological diseases like epilepsy or for pain treatment. Their research was published in the journal Science.
-
Thousands of Resident Physician Applicants Celebrate NRMP Match Results
3/15/2019
Today the National Resident Matching Program® (NRMP®) celebrates Match Day with the thousands of applicants and programs participating in the 2019 Main Residency Match®.
-
New Board of Directors for Association of Clinicians for the Underserved
3/15/2019
The Association of Clinicians for the Underserved (ACU), the premier organization of clinicians, advocates, and healthcare organizations that provide healthcare for the underserved, has announced the recent addition of two new members to its board of directors.
-
Pii to Manufacture FDA-approved Busulfan Injection Drug Product
3/15/2019
Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) headquartered in Hunt Valley, Maryland, is pleased to announce the launch of Busulfan Injection, 6mg/mL in 10mL vials, in partnership with Athenex Pharmaceuticals, Sungen Pharma and Chemwerth.
-
Statement from FDA Commissioner Scott Gottlieb, M.D., and Deputy Commissioner Frank Yiannas on advancing new tools and science for implementing agricultural water requirements for produce safety
3/15/2019
A critical component to growing, harvesting, packing and holding of fruits and vegetables for human consumption involves the use of agricultural water—water that's likely to come into contact with produce or food contact surfaces.
-
Mike Gimbel Teams up with Amatus Health to Combat Substance Abuse
3/15/2019
Former Baltimore County Drug Czar, Mike Gimbel, has partnered up with Amatus Health, a national behavioral health organization based in Owings Mills, Maryland.
-
Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on efforts to evaluate materials in medical devices to address potential safety questions
3/15/2019
We're in an unprecedented era of innovation in medical devices with advances in materials science that have led to technological breakthroughs such as the 3D printing of medical devices, continuous glucose monitoring patches for diabetes and miniaturized brain implants to treat epilepsy and Parkinson's disease.
-
In the wake of the scandal caused by a Chinese researcher’s use of CRISPR-Cas9 gene editing to alter the DNA of embryos for seven couples, leading scientists called for a moratorium on heritable genome editing.
-
Shares of Insys plunged more than 25 percent in trading Wednesday after the company said in a filing with the U.S. Securities and Exchange Commission that it could soon run out of revenue and may have to resort to liquidating its assets.
-
In addition to the planned BioNTech IPO, many other pharma and biotech companies in Europe, Asia and elsewhere shared news for the week.
-
FDA allows marketing of new device to help treat carbon monoxide poisoning
3/14/2019
The U.S. Food and Drug Administration today allowed marketing of a new device, ClearMate, intended to be used in an emergency room setting to help treat patients suffering from carbon monoxide poisoning
-
New Susan G. Komen® Study Unveils High Cost of Diagnostic Tests for Breast Cancer Serves as a Barrier to Needed Care
3/14/2019
According to a new study unveiled today by Susan G. Komen®, the world’s leading breast cancer organization, women across the country who have a suspicious finding from a screening mammogram are delaying, or even foregoing, needed diagnostic exams because of high out-of-pocket costs – with tragic potential consequences.